| Literature DB >> 31089467 |
Abstract
Nigella sativa (N. sativa) is one of important herbal foods in traditional medicine and many studies have conducted to show the effects of this plant on several diseases. The goal of this study was the evaluation of effects of bread with N. Sativa on clinical parameters such as blood glucose, blood pressure (BP) and anthropometry indices in subjects with metabolic syndrome (MetS). A study as double-blind, cross-over, randomized clinical trial was performed in 51 MetS patients in Chalus, north region of Iran. After dividing of patients randomly in 2 groups, in phase 1, intervention group (A, n = 27) used daily a bread with N. sativa and control group (B, n = 24) used the same bread but without N. sativa for 2 months. After considering of 15 day wash out period, phase 2 was began with changing of position of 2 groups. Measuring of parameters including fasting blood glucose (FBG), systolic blood pressure (SBP), diastolic blood pressure (DBP), weight, body mass index (BMI), and waist circumference (WC) was done before and after of 2 phases. After evaluation of treatment, sequence and time effects of intervention on parameters, it is shown that consumption of this bread has not significant treatment effect (as main effect) on FBG, SBP, DBP, WC, weight, and BMI (p > 0.05). Sequence effect on FBG, weight, WC, and BMI was significant (p < 0.05), but was not on BP. Time effect was only significant for DBP. Consumption of bread with N. sativa in MetS patients has not significant effect on FBG, BP, weight, WC, and BMI. TRIAL REGISTRATION: Iranian Registry of Clinical Trials Identifier: IRCT2015041821815N1.Entities:
Keywords: Anthropometry indices; Blood glucose; Blood pressure; Metabolic syndrome; Nigella sativa
Year: 2019 PMID: 31089467 PMCID: PMC6494753 DOI: 10.7762/cnr.2019.8.2.138
Source DB: PubMed Journal: Clin Nutr Res ISSN: 2287-3732
Comparison of approximate nutrient composition of 2 breads
| Nutrient (%) | Bread with | Bread without |
|---|---|---|
| Moisture | 38.7 | 41.3 |
| Ash | 1.2 | 0.8 |
| Carbohydrate | 48.0 | 47.5 |
| Protein | 6.6 | 7.3 |
| Fat | 2.6 | 1.0 |
| Fiber | 2.9 | 2.1 |
| Energy (kcal) | 241 | 228 |
Figure 1CONSORT flow diagram.
Biographic and clinical characteristics of participants
| Variable | Value | |
|---|---|---|
| Number | 51 | |
| Sex | ||
| Male | 30 (58.8) | |
| Female | 21 (41.2) | |
| Age (yr) | 47.5 ± 5.7 | |
| BMI (kg/m2) | 29.9 ± 3.8 | |
| History of dyslipidemia (%) | 62.7 | |
| History of diabetes (%) | 43.1 | |
| History of CVD (%) | 41.2 | |
Values are expressed as number (%) or mean ± standard deviation.
BMI, body mass index; CVD, cardiovascular disease.
Descriptive statistics of clinical indices in treatments, sequence and times effect of study by general linear model
| Study effects | Clinical indices | |||||||
|---|---|---|---|---|---|---|---|---|
| Treatment | Sequence | Time | Body weight (kg) | BMI (kg/m2) | WC (cm) | SBP (mmHg) | DBP (mmHg) | FBG (mg/dL) |
| A | AB | Pre | 80.04 ± 12.3 | 29.18 ± 4.0 | 97.89 ± 9.9 | 120.19 ± 12.8 | 74.44 ± 8.0 | 94.89 ± 15.8 |
| Post | 79.52 ± 12.5 | 28.99 ± 4.0 | 96.07 ± 8.6 | 115.93 ± 10.8 | 72.22 ± 10.0 | 81.56 ± 14.3 | ||
| BA | Pre | 83.46 ± 11. 2 | 30.64 ± 3.0 | 102.38 ± 7.1 | 117.08 ± 9.3 | 72.29 ± 8.0 | 99.54 ± 24.5 | |
| Post | 82.79 ± 11.6 | 30.39 ± 3.1 | 99.21 ± 7.6 | 114.17 ± 7.0 | 68.54 ± 7.4 | 88.50 ± 22.8 | ||
| B | AB | Pre | 79.7 ± 12.6 | 29.04 ± 4.07 | 96.04 ± 8.1 | 114.81 ± 8.3 | 70.93 ± 8.2 | 85.44 ± 17.0 |
| Post | 80.00 ± 12.5 | 29.15 ± 4.03 | 95.63 ± 9.8 | 112.96 ± 11.5 | 66.48 ± 7.9 | 86.93 ± 21.2 | ||
| BA | Pre | 83.75 ± 11.3 | 30.77 ± 3.34 | 102.33 ± 7.3 | 120.21 ± 11.0 | 73.96 ± 7.6 | 87.96 ± 23.5 | |
| Post | 83.71 ± 11.0 | 30.75 ± 3.17 | 101.33 ± 7.5 | 117.29 ± 14.8 | 72.50 ± 8.5 | 102.54 ± 25.4 | ||
Clinical indices are expressed as mean ± standard deviation. Participants in group A received a bread with N. sativa and in group B received a bread without N. sativa. AB presents the group who consumed firstly bread with N. sativa and after bread without it and BA presents the group who consumed firstly bread without N. sativa and after bread with it.
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; PRE, the beginning of phase; POST, the end of phase.
Effects of treatment, sequence, and time of study on clinical indices by general linear model
| Parameter | Treatment | Sequence | Time | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean square | F | p value | Mean square | F | p value | Mean square | F | p value | |
| Body weight | 5.845 | 0.041 | 0.840 | 663.170 | 4.647 | 0.032* | 2.751 | 0.019 | 0.890 |
| BMI | 0.837 | 0.062 | 0.803 | 121.848 | 9.066 | 0.003* | 0.404 | 0.030 | 0.863 |
| WC | 0.144 | 0.002 | 0.964 | 1,222.811 | 17.378 | 0.000 | 129.657 | 1.843 | 0.176 |
| SBP | 13.787 | 0.114 | 0.736 | 75.061 | 0.623 | 0.431 | 453.186 | 3.762 | 0.054 |
| DBP | 41.954 | 0.609 | 0.436 | 32.886 | 0.478 | 0.490 | 447.932 | 6.506 | 0.012* |
| FBG | 8.293 | 0.019 | 0.890 | 2,807.002 | 6.507 | 0.012* | 219.364 | 0.509 | 0.477 |
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose.
*p value of < 0.05 was considered as significant.